Finnrick - Ensuring a Safer and More Transparent Supply Chain
Shanghai Leader Peptide Biotechnology

Shanghai Leader Peptide Biotechnology

Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP agonist) from Shanghai Leader Peptide Biotechnology between 11 Feb 2026 and 2 Apr 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).

Finnrick Rating™
Shanghai Leader Peptide Biotechnology
Tirzepatide
Tested 6 Samples
Last test 2 Apr 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Shanghai Leader Peptide Biotechnology

Samples are tested in commercial labs

Tests Count

6

Scores

AVG6.0MIN0.0MAX10.0

Last

2 Apr 2026

First

11 Feb 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
2 Apr 2026View7.520mg20.3mg+1.5%99.70%(no batch ID)No Label / Silver Crimp / White CapLab GPublic
10 Mar 2026View10.020mg19.4mg-3.0%99.90%2026/03(no data)Lab EPublic
4 Mar 2026View0.020mg
⚠️ Sample does not contain Tirzepatide
(no batch ID)No Label / Silver Crimp / White CapLab EPublic
2 Mar 2026View5.810mg8.62mg-13.8%99.90%(no batch ID)No Label / Silver Crimp / Black CapLab EPublic
26 Feb 2026View7.415mg16mg+6.7%99.90%(no batch ID)No Label / Silver Crimp / Black CapLab EPublic
11 Feb 2026View5.440mg33.2mg-17.0%99.90%(no batch ID)No Label / Silver Crimp / Red CapLab EPublic